OSI Pharmaceuticals

Verasteam names Pachter VP, head of research

Thursday, August 4, 2011 01:11 PM

Verastem has named Jonathan Pachter, Ph.D., vice president and head of research.

More... »


NeoStem names Joseph Talamo VP

Friday, July 1, 2011 10:36 AM

Joe Talamo has joined biopharmaceutical company NeoStem as vice president, corporate controller and chief accounting officer. Previously he held senior positions at OSI Pharmaceuticals as its vice president and corporate controller.

More... »


BRANY names new board member

Friday, July 1, 2011 10:29 AM

Biomedical Research Alliance of New York (BRANY) has added a biotechnology expert to its board of directors. Robert L. Van Nostrand has extensive experience in biotechnology finance, including roles as as executive vice president and chief financial officer at OSI Pharmaceuticals, Aureon Biosciences and AGI Dermatics. He has also served as chairman of the New York Biotechnology Association (NYBA) on which he remains an active board member.

More... »

Astellas to sell diabetes patents

Friday, July 1, 2011 10:13 AM

Japanese drug maker Astellas Pharma is selling its diabetes-related patents to a fund for $609 million, to then be invested in strategic initiatives, according to Reuters.

More... »

Regulus Therapeutics appoints Neil W. Gibson as CSO

Monday, April 18, 2011 01:09 PM

Regulus Therapeutics, a biopharmaceutical company that discovers and develops new medicines targeting microRNAs, has appointed Neil Gibson, Ph.D., as its chief scientific officer. 

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.